(IBDT) iShares iBonds Dec 2028 - Ratings and Ratios
Bonds, Corporate, Investment-Grade, U.S., Non-U.S
Dividends
| Dividend Yield | 4.60% |
| Yield on Cost 5y | 4.78% |
| Yield CAGR 5y | 13.70% |
| Payout Consistency | 95.5% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 1.24% |
| Value at Risk 5%th | 1.96% |
| Relative Tail Risk | -3.91% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.16 |
| Alpha | 2.63 |
| CAGR/Max DD | 1.25 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.422 |
| Beta | 0.019 |
| Beta Downside | -0.011 |
| Drawdowns 3y | |
|---|---|
| Max DD | 4.19% |
| Mean DD | 0.85% |
| Median DD | 0.51% |
Description: IBDT iShares iBonds Dec 2028 January 12, 2026
The iShares iBonds Dec 2028 Term Corporate ETF (NYSE ARCA: IBDT) is a target-maturity fund that must allocate at least 80% of its assets to the securities comprising its underlying index and at least 90% to fixed-income instruments that meet the index’s criteria. The index tracks U.S.-dollar-denominated, investment-grade corporate bonds issued by U.S. and non-U.S. issuers with a minimum $300 million of outstanding face value.
As of the latest reporting period, IBDT carries an effective duration of roughly 7.5 years and a weighted-average credit rating of A- (Moody’s) or A3 (S&P), reflecting its focus on higher-quality issuers. The fund’s 12-month yield sits near 4.2%, a level that is sensitive to Federal Reserve policy and the broader corporate credit spread environment; a tightening of monetary policy or a widening of spreads could depress price performance, while a flattening yield curve may support the fund’s total return.
For a deeper quantitative view-including scenario-based stress testing and forward-looking credit outlooks-consider exploring the analytics on ValueRay, which can help you gauge how changes in interest rates and credit conditions might affect IBDT’s risk-adjusted returns.
What is the price of IBDT shares?
Over the past week, the price has changed by +0.08%, over one month by +0.35%, over three months by +0.88% and over the past year by +6.87%.
Is IBDT a buy, sell or hold?
What are the forecasts/targets for the IBDT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 27.5 | 8% |
IBDT Fundamental Data Overview January 17, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.66b USD (3.66b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.66b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.66b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.98% (E(3.66b)/V(3.66b) * Re(5.98%) + (debt-free company))
Discount Rate = 5.98% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBDT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle